Darbepoetin alfa is indicated for:
Population group: only adults (18 years old or older)
Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Darbepoetin alfa is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
